Rubella virus vaccine associated arthropathy in postpartum immunized women: Influence of preimmunization serologic status on development of joint manifestations

Journal of Rheumatology

Volumn 27, Issue 2, 2000, Pages 418-423

  Mitchell, Leslie Ann ^a   Tingle, Aubrey J ^b   Grace, Michael ^b   Middleton, Peter ^b   Chalmers, Andrew C ^b  

^a CHILDREN S AND WOMEN S HEALTH CENTRE OF BRITISH COLUMBIA   (Canada)

^b NONE

Author keywords

Antibodies; Arthropathy; Immunity; Rubella Virus; Vaccination

Indexed keywords

RUBELLA VACCINE;

ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ANTIBODY TITER; ARTHROPATHY; ARTICLE; ENZYME IMMUNOASSAY; FEMALE; HIGH RISK POPULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; PUERPERIUM; RUBELLA VIRUS; SERODIAGNOSIS; VACCINATION; VIRUS DETECTION;

ADULT; ANTIBODIES, VIRAL; COHORT STUDIES; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOGLOBULIN G; JOINT DISEASES; POSTPARTUM PERIOD; RUBELLA VIRUS; VACCINATION; VIRAL VACCINES;

EID: 0033962723     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Howson CP, Howe CJ, Fineberg HV, editors. Adverse effects of pertussis and rubella vaccines: a report of the Committee to Review the Adverse Consequences of Pertussis and Rubella Vaccines. Division of Health Promotion and Disease Prevention, Institute of Medicine, National Academy Press, Washington, DC; 1991:1-205.
2. Tingle AJ, Mitchell LA, Grace M, et al. Randomised double-blind placebo-controlled study on adverse effects of rubella immunisation in seronegative women. Lancet 1997;349:1277-81.
3. Tingle AJ, Pot CH, Chantler JK. Prolonged arthritis, viraemia, hypogammaglobulinaemia, and failed seroconversion following rubella immunisation [letter]. Lancet 1984;30:1475-6.
4. Tingle AJ, Pot KH, Yong FP, et al. Kinetics of isotype-specific humoral immunity in rubella vaccine-associated arthropathy. Clin Immunol Immunopathol 1989;53:S99-S106.
5. Klinkhoff AV, Bellamy N, Bombardier C, et al. An experiment in reducing intraobserver variability for the examination of joint tenderness. J Rheumatol 1988;15:492-4.
6. Tingle AJ, Chantler JK, Pot KH, et al. Postpartum rubella immunization: association with development of prolonged arthritis, neurological sequelae, and chronic rubella viremia. J Infect Dis 1985;152:606-12.
7. Mitchell LA, Zhang T, Ho M, et al. Characterization of rubella virus-specific antibody responses by using a new synthetic peptide-based enzyme-linked immunosorbent assay. J Clin Microbiol 1992;30:1841-7.
8. Zrein M, Joncas JH, Pednault L, et al. Comparison of a whole virus enzyme immunoassay (EIA) with a peptide-based EIA for detecting rubella virus immunoglobulin G antibodies following rubella vaccination. J Clin Microbiol 1993;31:1521-4.
9. Technical report series no. 463. WHO Expert Committee on Biological Standardization 23rd Report. Geneva: World Health Organization: 1971:18.
10. Zhang T, Mauracher CA, Mitchell LA, et al. Detection of rubella virus-specific immunoglobulin G (IgG), IgM, and IgA antibodies by immunoblot assays. J Clin Microbiol 1992;30:824-30.
11. Mitchell LA, Tingle AJ, Shukin R, et al. Chronic rubella vaccine-associated arthropathy. Arch Intern Med 1993;153:2268-74.
12. Skendzel LP. Rubella immunity. Defining the level of protective antibody. Am J Clin Pathol 1996;106:170-4.
13. NCCLS document I/LAB-T. vol 12. Villanova, PA: National Committee for Clinical Laboratory Standards: 1992:1-3.
14. Eisele CJ. Rubella susceptibility in women of childbearing age. J Obstet Gynecol Neonatal Nursing 1993;22:260-3.
15. Frenkel LM, Nielsen K, Garakian A, et al. A search for persistent rubella virus infection in persons with chronic symptoms after rubella and rubella immunization and in patients with juvenile rheumatoid arthritis. Clin Infect Dis 1996;22:287-94.
16. Serdula MK, Halstead SB, Wiebenga NH, et al. Serological response to revaccination. JAMA 1984;251:1974-7.
17. Mitchell LA, Ho MK-L, Rogers JE, et al. Rubella reimmunization: comparative analysis of the immunoglobulin G response to rubella virus vaccine in previously seronegative and seropositive individuals. J Clin Microbiol 1996;34:2210-8.
18. Chantler JK, Tingle AJ, Petty RE. Persistent rubella virus infection associated with chronic arthritis in children. N Engl J Med 1985;313:1117-23.
19. Chantler JK, Ford DK, Tingle AJ. Persistent rubella infection and rubella-associated arthritis. Lancet 1982;1:1323-5.
20. Chaye H, Ou D, Chong P, Gillam S. Human T- and B-cell epitopes of E1 glycoprotein of rubella virus. J Clin Microbiol 1993; 13:93-100.
21. Wolinsky JS, Sukholutsky E, Moore WT, et al. An antibody and synthetic peptide-defined rubella virus E1 glycoprotein neutralization domain. J Virol 1993;67:961-8.
22. Ho-Terry L, Terry GM, Cohen A, et al. Immunological characterisation of the rubella E1 glycoprotein. Arch Virol 1986;90:145-52.
23. Green KY, Dorsett PH. Rubella virus antigens: localizalion of epitopes involved in hemagglutination and neutralization by using monoclonal antibodies. J Virol 1986;57:893-8.